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Abstract

Background: Bladder health in women and girls is poorly understood, in part, due to absence of a definition for
clinical or research purposes. This article describes the process used by a National Institutes of Health funded
transdisciplinary research team (The Prevention of Lower Urinary Tract Symptoms [PLUS] Consortium) to
develop a definition of bladder health.
Methods: The PLUS Consortium identified currently accepted lower urinary tract symptoms (LUTS) and outlined
elements of storage and emptying functions of the bladder. Consistent with the World Health Organization’s
definition of health, PLUS concluded that absence of LUTS was insufficient and emphasizes the bladder’s ability
to adapt to short-term physical, psychosocial, and environmental challenges for the final definition. Definitions for
subjective experiences and objective measures of bladder dysfunction and health were drafted. An additional
bioregulatory function to protect against infection, neoplasia, chemical, or biologic threats was proposed.
Results: PLUS proposes that bladder health be defined as: ‘‘A complete state of physical, mental, and social
well-being related to bladder function and not merely the absence of LUTS. Healthy bladder function permits
daily activities, adapts to short-term physical or environmental stressors, and allows optimal well-being (e.g.,
travel, exercise, social, occupational, or other activities).’’ Definitions for each element of bladder function are
reported with suggested subjective and objective measures.
Conclusions: PLUS used a comprehensive transdisciplinary process to develop a bladder health definition. This
will inform instrument development for evaluation of bladder health promotion and prevention of LUTS in
research and public health initiatives.
Keywords: bladder, definition, health, urinary tract
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DEFINING BLADDER HEALTH IN WOMEN AND GIRLS
Introduction

L

ower urinary tract symptoms (LUTS) are highly
prevalent affecting up to one in three women and girls
and become increasingly common over the life course.1,2
LUTS include patient-reported symptoms related to urine
storage and emptying, which negatively impact quality of
life.3 Lower urinary tract dysfunctions such as urinary tract
infections (UTIs, i.e., bladder infections), urinary incontinence (UI), overactive bladder, bladder pain syndrome/
interstitial cystitis, incomplete emptying, and bladder cancer
are typically associated with LUTS. Certain medical conditions also contribute to LUTS (e.g., neurologic disease, heart
disease, diabetes, constipation, and autoimmune diseases).4–6
Psychosocial, behavioral, and environmental conditions can
have an impact on LUTS and bladder health, particularly in
young girls.7–10 Between 20 and 40% of children and adolescents with LUTS have associated mental health conditions
such as anxiety, attention deficit hyperactivity disorder, or
oppositional defiant disorder.11 In addition, urinary symptoms have been reported in 65.7% of young athletes.10 In
adults, LUTS have been associated with decreased sexual
enjoyment, poor sleep quality, lower productivity, depression, and poor health-related quality of life.3,12–16 Alarmingly, more than 50% of seriously ill hospitalized patients
>60 years of age reported that they considered death preferable to incontinence.17
While LUTS are common in women and have a negative
impact on quality of life, most women do not seek treatment.18,19 In a survey of working women, more than one in five
had experienced UI at least monthly; however, fewer than half
of those women sought care. A more recent epidemiologic
study linked to electronic health records of 3316 women in
Pennsylvania found that only 25% of women with UI sought
care.19,20 Stigma associated with LUTS may reduce treatmentseeking behaviors.21 Many women cope with their symptoms
through limiting fluids, scheduled urination, using absorbent
products (e.g., pads, panty liners), and other self-management
strategies.20 Some self-management strategies reduce symptom bother allowing normal activities, whereas others (e.g.,
limiting social activities) can negatively affect quality of life.
The growth of marketing campaigns for absorbent products for
UI (an industry estimated to reach $2.7B by 2020) may contribute to reducing stigma and increasing treatment-seeking
behaviors.22,23 Alternatively, such campaigns may normalize
LUTS and reinforce perceptions that LUTS are part of aging or
being female.19,24 An unintended consequence of this normalization of LUTS is potentially a lack of awareness of and
motivation to pursue promising prevention and treatment options, leading instead to unhealthy self-management, including
tolerating symptoms.25
While numerous effective treatment options for LUTS
exist, there is sparse evidence informing optimal bladder
health promotion and LUTS prevention strategies. Most
primary prevention trials focus purely on one particular
LUTS (e.g., UI) and are targeted toward women at high risk
of developing LUTS. Evidence supports the use of pelvic
floor exercise programs for prevention of UI during pregnancy and in older populations, but outcomes for other LUTS
such as urinary infections, voiding dysfunction, or pain are
unknown.26–29 Recent reviews of primary prevention of UTIs
focus on nursing home and postmenopausal women with
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outcomes for UTIs, but do not describe the impact on other
LUTS.30,31 Although these prevention strategies appear to be
effective, we cannot know if they truly promote overall
bladder health. In part, this is because current research is not
informed by a standardized definition of bladder health that
guides the selection of measures used to evaluate prevention
efforts. To accurately identify and promote optimal bladder
health, a systematic, evidence-based approach to defining
bladder health across the life course is first needed. A standardized definition of bladder health can aid in the identification of factors to promote health and modify risk factors for
LUTS. We propose a new paradigm to define optimal bladder
health extending beyond mere lack of symptoms to include
concepts of well-being and resilience to short-term challenges to health.
The primary objectives of this work were twofold: (1) to
describe the process used by our transdisciplinary consortium
to develop a working research definition of bladder health
and (2) to present the resulting bladder health definition that
is proposed for use in research and public health.
Materials and Methods
Conceptualizing bladder health

The transdisciplinary Prevention of Lower Urinary Tract
Symptoms (PLUS) Consortium is funded by the National
Institutes of Health to advance research on LUTS prevention
in women and girls. The purpose, organization, and function
of the PLUS Consortium are described in detail by Harlow
et al.32 There was broad consensus across PLUS investigators
that a definition of bladder health was a necessary first step to
plan, perform, and evaluate the research required to advance
LUTS prevention in women and girls. The absence of a
commonly accepted definition of bladder health has hindered
development of a comprehensive bladder health promotion
and LUTS prevention agenda.25,33 To date, bladder health
has been framed in terms of absence of LUTS symptoms, an
approach that ignores quality of life and the dynamic nature
of health over the life course.34,35 To this end, PLUS investigators acknowledged the need for a working definition of
bladder health and adapted The World Health Organization’s
(WHO) definition of health as a framework. WHO asserts
that ‘‘health is a state of complete physical, mental, and social
well-being and not merely the absence of disease or infirmity.’’36 In addition to the WHO definition, PLUS investigators considered more recent work by Huber et al., who
contend that in the age of chronic disease, complete wellbeing may be an unattainable standard, particularly at later
stages in the life course; they suggest redefining health as
‘‘the ability to adapt and to self-manage,’’ recognizing the
changing and multidimensional nature of health in a dynamic
environment.37 The deliberations of the PLUS investigators
distinguished between two types of adaptations described by
Huber et al. and others.37–39 The first type of adaptation—
self-management—includes compensatory behaviors in response to environmental constraints on timing of urination
(e.g., restricting fluid intake) and containment behaviors in
response to symptoms (e.g., wearing incontinence protection
to fully engage in desired activities). For better or worse,
terms have been developed to define and ‘‘medicalize’’ the
latter self-management strategies (i.e., contained incontinence—UI that is controlled by being contained with an
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absorbent product or a collecting device).40 The second type
of adaptation—resilience—occurs throughout the life course
and is consistent with the concept of allostasis, the body’s
capability of regaining homeostasis after physical, psychosocial, or environmental challenges to the organ system (e.g.,
complete recovery after a UTI).38,41 Resilience throughout
the life course may prevent the development of LUTS and
therefore the need for self-management strategies (e.g.,
wearing incontinence protection). The PLUS Consortium
emphasized the concept of resilience in developing a definition of bladder health to capture the concept as not merely
the absence of LUTS, but also the bladder’s ability to adapt to
short-term physical, psychosocial, and environmental
stressors without lasting harm to the system.36–38,41 This requires a definition that addresses the concepts of well-being
and resilience to stressors and is distinct from ‘‘selfmanagement’’ strategies to cope with LUTS.
Considering bladder health in women and girls
across the life course

Although overall prevalence of LUTS may be similar in
men and women, the mechanisms by which LUTS affect
females differ from that of males.13,42 Females are disproportionately affected by some LUTS, with women having nearly
thrice higher prevalence of UI and bladder pain syndrome than
men.43,44 Therefore, the work of the PLUS Consortium is focused exclusively on women and girls, which are an understudied population with unique needs for bladder health
promotion research. To understand bladder health across the
life course in women and girls, it is also important to recognize
biologic changes in development and exposures to risk and
protective factors that occur over time. PLUS investigators
intended for the proposed definition of bladder health to be used
across a wide age spectrum, acknowledging changes that occur
at the various stages of life and that well-being, resilience, and
risk may vary over the life course.45,46 The Consortium proposed five developmental stages important in the study of
bladder health across the life course: Childhood (£10 years),
Adolescence (11–17 years), Emerging Adulthood (18–25
years), Adulthood (26–64 years), and Older Adulthood (‡65
years). Using these proposed life stages, researchers can expand
understanding of risk factors for LUTS and protective factors
for bladder health by identifying populations across the life
course with varying degrees of bladder health. For example,
novel prevention opportunities may exist for children, adolescents, and young women at various developmental time points
(e.g., toilet training, school entry, puberty, sexual debut, and
pregnancy).
The PLUS process

The process began with exploration of lessons learned
from other health promotion campaigns (e.g., cardiovascular
health); however, the lack of evidence for bladder health risk
and protective factors prohibited use of a similar mode to that
used in cardiovascular health. Thus, PLUS investigators used
an iterative process to define bladder health and formed a
transdisciplinary Terminology, Conceptual Frameworks and
Models (TCFM) group to lead the activity. The TCFM group
included two co-chairs (one with clinical and another with
public health expertise) and 12 investigators with expertise in
urogynecology, obstetrics and gynecology, nursing, pediat-
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rics, geriatrics, public health, and behavioral sciences. The
priority for the TCFM group was to establish a common
language for PLUS, think conceptually about bladder health,
and to propose a bladder health definition to the PLUS
Consortium for consideration, refinement, and approval. The
consortium and TCFM group’s approach was consistent with
Mohammed and Dumville’s integrative framework of team
knowledge.47 This framework includes the processes of information sharing (i.e., group discussion and information
exchange), transactive memory (i.e., utilizing group members as memory aids), group learning (i.e., construction of
new knowledge by the group), and cognitive consensus (i.e.,
reconciling different perspectives to define and conceptualize
key issues). These processes guided taskwork, teamwork, and
representation of key issues. The PLUS approach to developing a bladder health definition was also similar to how
another transdisciplinary group of experts studied healthcare
delivery in low- and middle-income countries.48
A framework table of bladder storage and emptying
functions was initially drafted, and with collaboration from
other PLUS investigators, the TCFM group mapped accepted
LUTS definitions associated with various bladder dysfunctions to a list of elements of bladder function.40,49–53 Consideration of the elements of bladder function was a useful
bridge in developing definitions for healthy bladder functions. In addition, we took the novel step of including a
bioregulatory function of the bladder to acknowledge the
roles of the bladder lining and urine composition in bladder
health and dysfunction. ‘‘Bladder Health’’ and ‘‘Bladder
Dysfunction’’ definitions were proposed for each bladder
function: storage, emptying, and bioregulatory. The definitions took into account the known variation across the life
course (e.g. development of continence in children is reliant
on bladder maturation and appropriate neurodevelopmental
function, while storage capacity and emptying efficiency may
change with advanced age).
An iterative process was used to develop and refine
terminology and the proposed definitions for health and
dysfunction. Beginning in September 2015, PLUS TCFM
members engaged in biweekly organized web-based discussions about definition development. Based on expertise, investigators were assigned to subgroups to advance work on
each element of bladder function pertaining to the definition.
Clinical experts shared existing knowledge of LUTS, while
other experts broadened that knowledge to improve understanding for nonclinical audiences. To obtain input and refine
the emerging definition, the TCFM investigators regularly
shared progress with and received input from the entire PLUS
Consortium through webinars and during in-person PLUS
meetings. In addition, during in-person meetings, TCFM
members led small group activities for all PLUS investigators
to identify gaps in the definition and assess areas of uncertainty. By July 2017, the PLUS Consortium achieved consensus and approved the definitions for the elements of
bladder function for use in development of a bladder health
measurement questionnaire.
Results
The PLUS definition of bladder health

The working PLUS Definition of Bladder Health is as
follows:
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LUTS/subjective
experience(s)
Objective measure(s)

Subjective, experience(s)

Symptoms that occur during
emptying—e.g., hesitancy,
straining (at initiation and to
completely empty), slow
stream, interrupted stream,
spraying/splitting, feeling of
incomplete emptying,
postvoid dribble, inability to
sense when flow is complete,
or dysuria

Objective, measure(s)

Physical finding or measure
related to healthy storage—
e.g., healthy first sensation,
strong desire to void,
maximum capacity,
functional capacity,
duration of time between
urge and void, duration of
time between voids
Measurable findings or signs The ability to empty the
Physical finding or measure
bladder completely in a
related to LUTS that occur
related to healthy
timely, efficient, effortless,
during the emptying of the
emptying—e.g., time to
comfortable manner and
bladder—e.g., premature or
initiation of stream,
resume continencea
delayed initiation of
duration of total void,
stream, flow pattern, flow
character of stream,
- Time to go from urge (delay
rate, elevated postvoid
minimal to no postvoid
in initiation of flow)
residual
residual urine volume
- Duration of emptying
- Completeness of emptying
- Urine flow stops when
desired
NA
Measurable findings related to
Measurable findings related
define healthy bioregulatory
to the breakdown in the
measures—e.g., biomarkers,
protective and
microbiome, proteins that
communication functions
are adaptable to short-term
of the bladder resulting
physical or environmental
in LUTS—e.g., infection,
stressors, able to completely
inflammation, collagen
recover from disruption,
degradation, malignancy
without long-term or
persistent sequelae

Ability to hold urine for a
Physical finding or measure
Bothersome LUTS that occur
reasonable duration of time
related to LUTS during
during storage—e.g.,
and sense bladder fullness
storage—e.g., small
increased daytime frequency,
without fear of or concern
bladder capacity, decreased
nocturia, urinary incontinence,
about urgency, discomfort,
time between voids,
enuresis, nocturnal enuresis,
or leakagea
detrusor overactivity,
postvoid dribble, urgency,
urinary leakage
absence of urge, bladder pain

NA
Biosis barrier
Physical/chemical barrier
Cancer barrier

Capacity
- Day/waking
- Night/sleeping
Continence
- Day/waking
- Night/sleeping
Sensation
- Urge
- Comfort
Initiation
Stream flow
- Speed
- Character
- Continuity
Efficacy
Sensation
- Relief of urge
- Completeness
- Comfort

Elements of function

Bladder health

a
Function does not impact daily activities on a routine basis, is adaptable to short term physical or environmental stressors, and allows a woman to pursue her optimal well-being (e.g. travel,
exercise, social, occupational or other activities).
LUTS, lower urinary tract symptoms; NA, not applicable.

Bioregulatory

Emptying

Storage

Bladder function

Bladder dysfunction

Table 1. Overview of Prevention of Lower Urinary Tract Symptoms Consortium Bladder Dysfunction and Health in Women and Girls
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‘‘A complete state of physical, mental, and social wellbeing related to bladder function and not merely the absence
of LUTS. Healthy bladder function permits daily activities,
adapts to short-term physical or environmental stressors,
and allows optimal well-being (e.g., travel, exercise, social,
occupational, or other activities).’’

Underlying this overall definition, PLUS developed
definitions for each of the three functions of the bladder
(Table 1). The storage function of the bladder requires that
the bladder acts as a low-pressure reservoir with a competent
urethra that maintains pressure against increased abdominal
pressure and communicates the state of bladder fullness via
an intact nervous system. The defined elements of storage
include: capacity (as measured by frequency of urination and
storage volume), continence, and sensation (including comfort and urge). The emptying function of the bladder requires
a sustained bladder contraction with relaxation of the urethra
until urine is emptied completely, with an intact nervous
system to communicate the state of bladder emptiness. The
defined elements of emptying include: stream initiation,
stream flow characteristics, efficacy of urination, and sensation (i.e., relief of urge, completeness, and comfort). We
acknowledged that the elements of storage and emptying
functions may be different during daytime (waking) and
nighttime (sleeping) hours, which are reflected in the symptoms of dysfunction as defined by current International
Continence Society (ICS) and International Children’s
Continence Society (ICCS) terminology.40,49–53 For each
element of storage and emptying we identified subjective
experience and objective features of bladder function and
dysfunction (Table 1).
During development of these definitions, PLUS investigators acknowledged that the proposed categorization of bladder
functions differs slightly from previously described bladder
phases of storage, emptying, and postmicturition.42,54,55 In
health, we did not consider ‘‘postmicturition’’ as a bladder
function; rather we acknowledged it as a time interval whereby
dysfunction in emptying or storage could occur. The healthy
bladder should transition from emptying to storage without a
defined ‘‘postmicturition’’ health state. In contrast, postvoid
dribble is a LUTS that can be manifest in either storage or
emptying dysfunctions. To acknowledge that postvoid dribble
is likely a multifactorial condition, we present this dysfunction
in both storage and emptying dysfunction.
The bladder bioregulatory function focuses more broadly on
lower urinary tract dysfunction. Bioregulation was considered
as bidirectional communication between the bladder and the
environment that prevents systemic or local infection, transmits
appropriate physiologic signals, or regulates cellular function.
In health, the bladder barrier protects the individual from
pathogens, chemicals, and malignancy; it is adaptable to shortterm physical, psychosocial, or environmental stressors; and it
is able to recover from disruption without long-term or persistent sequela. A breakdown of the protective barrier may lead
to infection, inflammation, malignancy, or other maladies. The
bioregulatory function is subdivided into three main functions
as follows: (1) Biosis barrier (representing the host-defense
system), (2) physical/chemical barrier (preventing toxins from
penetrating beyond the mucosal layer), and (3) cancer barrier
(preventing malignant expression of bladder tissues). These
functions include many biomarkers and ‘‘-nomics’’ (e.g. genomics, proteomics, and metabolomics) related to lower uri-
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nary tract dysfunction. The list is intended to acknowledge the
breadth of markers being studied, rather than serving as an
exhaustive list that represents all known mechanisms for LUTS
or bladder health. Biological markers of this sort may be
identified in the healthy bladder, and they will be considered
when measuring bladder health and outcomes in prevention
studies.
The PLUS Consortium bladder health and dysfunction
working table serves as a repository of working terminology
and as a resource to help develop an instrument to measure
bladder health, identify gaps in knowledge regarding health
and dysfunction, and highlight areas for future bladder health
research. A distillation of this work is presented in Table 1.
Discussion

The PLUS definition of bladder health has been systematically created to guide the selection of measures and develop an evidence base for LUTS prevention and bladder
health promotion. This foundational work will further the
efforts of the PLUS Consortium and the broader research
community in the development of cross-sectional and longitudinal studies. This definition provides a starting point for
the PLUS research agenda designed to describe the spectrum
of bladder health in women and girls and to enable the exploration of risk and protective factors for LUTS and bladder
health. Refinements to this first PLUS bladder health definition will undoubtedly occur as PLUS investigators incorporate new information from emerging scientific evidence,
including qualitative research. The importance of community
engagement, with broad stakeholders, is essential to this effort, and key stakeholders will provide input to further evolve
the PLUS bladder health definition. This description of our
process and transdisciplinary approach may inform others
studying conditions with similar needs and challenges in
expanding beyond a focus on symptoms (e.g., bowel health,
mental health, and so on).
PLUS investigators have already begun the work of developing and validating bladder health measurement tools for use
in various research endeavors, including basic, clinical, and
translational science and public health; these tools will be used
to assess the spectrum of bladder health. Existing LUTS
measurement tools are being evaluated to determine those that
can be modified to measure bladder health. In addition, measures are being developed to capture elements of health-related
factors, including full participation in desired activities and to
resilience to short-term physical, psychosocial, and environmental stressors without lasting harm to the system. The PLUS
Consortium plans to collect normative objective data for
proposed bladder functions (e.g., storage, emptying, and
bioregulatory), study the prevalence of bladder health in the
population, and to identify risk and protective factors associated with incidence of LUTS and maintenance of bladder
health in women and girls. Establishment of a biobank for
biological samples, including serial samples in women and
girls with healthy bladders, will also advance our understanding of bladder health and incident of LUTS.
Conclusions

As a key initiative of the PLUS Research Consortium,
investigators offer this description of the process for developing a bladder health definition in women and girls. This
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critical first step is essential to support research activities to
measure and influence bladder health and LUTS prevention
on a population level.
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